The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
The role of short-chain fatty acids in microbiota–gut–brain communication
Open accessAbstract
Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fibre in the gastrointestinal tract, are speculated to have a key role in microbiota-gut-brain crosstalk. However, the pathways through which SCFAs might influence psychological functioning, including affective and cognitive processes and their neural basis, have not been fully elucidated. Furthermore, research directly exploring the role of SCFAs as potential mediators of the effects of microbiota-targeted interventions on affective and cognitive functioning is sparse, especially in humans. This Review summarizes existing knowledge on the potential of SCFAs to directly or indirectly mediate microbiota-gut-brain interactions. The effects of SCFAs on cellular systems and their interaction with gut-brain signalling pathways including immune, endocrine, neural and humoral routes are described. The effects of microbiota-targeted interventions such as prebiotics, probiotics and diet on psychological functioning and the putative mediating role of SCFA signalling will also be discussed, as well as the relationship between SCFAs and psychobiological processes. Finally, future directions to facilitate direct investigation of the effect of SCFAs on psychological functioning are outlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The gut microbiota influences gut barrier and produce neurotransmitters, amino acids and microbial metabolites61.”
From Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“gut microbiota dysbiosis has been implicated in behavioral and neurologic pathologies, such as depression, Alzheimer's (AD) and Parkinson's (PD) diseases and autism spectrum disorder (ASD) (9, 21, 25–27).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“brain to gut signaling can directly affect the microbiota, either via immune system or gut functions such as motility, release of neurotransmitters and intestinal immune tone (12, 17, 21, 31).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the gut microbiota can interact with the CNS via gut modulation or directly via metabolites and endotoxin translocation from the lumen to the circulation (9, 17, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“altered SCFA production has been demonstrated in a variety of neuropathologies (19, 21, 33–35).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these SCFAs regulate the expression levels of tryptophan 5-hydroxylase 1, the enzyme involved in synthesis of serotonin, and tyrosine hydroxylase, which is involved in a rate-limiting step in the biosynthesis of dopamine, noradrenaline and adrenaline; therefore, producing an effect on brain neurochemistry (21, 55, 56, 116, 117).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microbial metabolites such as short chain fatty acids (SCFAs) exert beneficial effects on psychiatric disorders via the microbiota–gut–brain axis through humoral, hormonal, and immune pathways [12].”
From Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SCFAs exert their physiological activities by acting as endogenous ligands for G-protein-coupled receptors (GPCRs), and modulating gene expression by inhibiting histone deacetylases (HDACs).282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“SCFAs can modulate the levels of neurotransmitters and neurotrophic factors and regulate the expression of tryptophan 5-hydroxylase, the enzyme involved in the synthesis of serotonin, and tyrosine hydroxylase, the enzyme involved in the rate-limiting step in dopamine, noradrenaline, and adrenaline synthesis (18, 132, 164, 222).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
The cited source says what the claim attributes to it.
In the citing paper
“Other pathways through which SCFAs can influence gutbrain communication and brain function include immune, endocrine, neuronal, vagal, and other humoral pathways (360).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [360]
The cited source says what the claim attributes to it.
In the citing paper
“growing evidence supports the idea that SCFAs also exert crucial physiological effects on several organs, including the brain (17, 20, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Accumulating evidence suggests that SCFAs that cross into the CNS have neuroactive properties.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“It was described that SCFAs may modulate the levels of neurotransmitters and neurotrophic factors.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
In the citing paper
“SCFAs are endogenous ligands for a subset of GPCRs, including GPR43 and GPR41, which were subsequently renamed as free fatty acid receptor 2 (FFAR2) and FFAR3, respectively.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“Another important GPCR activated by SCFA is GPR109A, also known as hydroxycarboxylic acid receptor 2 (HCAR2), which is activated by butyrate and β-D-hydroxy butyrate.282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“and intracellular SCFAs can influence gene expression via histone deacetylation (HDAC) inhibition (Dalile et al., 2019)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Moreover, SCFAs are endogenous ligands of orphan G protein-coupled receptors (GPCRs)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Altered SCFA production has also been demonstrated in a variety of neuropathologies (42, 116, 127, 130, 132, 292–295).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Self-citationCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Cited by
Sorted by citations
Items 701–800 of 1,008
Yi, C., Huang, S., Zhang, W., Guo, L., Xia, T., Huang, F., Yan, Y., Li, H., & Yu, B. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107231 · Cited by 41
Ma, B., Barathan, M., Ng, M. H., & Law, J. X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073148 · Cited by 41
Kurhaluk, N., Kołodziejska, R., Kamiński, P., & Ткаченко, Г. М. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311706 · Cited by 43
Nutrition, Microbiota and Role of Gut-Brain Axis in Subjects with Phenylketonuria (PKU): A Review
Verduci, E., Carbone, M. T., Borghi, E., Ottaviano, E., Burlina, A., & Biasucci, G. (2020) · Nutrients · doi:10.3390/nu12113319 · Cited by 41
The Development of Early Life Microbiota in Human Health and Disease
Lv, H., Zhang, L., Han, Y., Wu, L. M., & Wang, B. (2021) · Engineering · doi:10.1016/j.eng.2020.12.014 · Cited by 40
Yu, Z., Xie, Y., Huang, Z., Yang, K., Wang, Z.-G., & Hu, H. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153538 · Cited by 41
APOE genetics influence murine gut microbiome
Zajac, D. J., Green, S. J., Johnson, L. A., & Estus, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-05763-1 · Cited by 41
Ticinesi, A., Mancabelli, L., Carnevali, L., Nouvenne, A., Meschi, T., Rio, D. D., Ventura, M., Sgoifo, A., & Angelino, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215493 · Cited by 41
Xu, J., Tang, M., Wu, X., Kong, X., Liu, Y., & Xu, X. (2022) · Food & Function · doi:10.1039/d1fo03804d · Cited by 41
Wang, W., Xu, C., Zhou, X., Zhang, L., Gu, L., Liu, Z., Ma, J., Hou, J., & Jiang, Z. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c01950 · Cited by 41
Convergent pathways of the gut microbiota–brain axis and neurodegenerative disorders
Gubert, C., Gasparotto, J., & Morais, L. H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac017 · Cited by 40
Antibiotic-induced microbiome depletion improves LPS-induced acute lung injury via gut-lung axis
Hashimoto, Y., Eguchi, A., Wei, Y., Shinno-Hashimoto, H., Fujita, Y., Ishima, T., Chang, L., Mori, C., Suzuki, T., & Hashimoto, K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120885 · Cited by 41
Xiao, W., Li, J., Gao, X., Yang, H., Su, J., Weng, R., Gao, Y., Ni, W., & Gu, Y. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114225 · Cited by 41
Zhu, L., Chen, J., Pi, X., Li, J., Liu, W., Ding, Q., Wang, X., & Jia, W. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02103-7 · Cited by 40
Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson’s disease
Anis, E., Xie, A., Brundin, L., & Brundin, P. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.11.005 · Cited by 40
Zhang, Z., Deng, S., Chen, C., He, Q., Peng, X., Liang, Q., Zhuang, G., Wang, S., & Tang, D. (2023) · Phytotherapy Research · doi:10.1002/ptr.7827 · Cited by 40
Yu, L., Gao, Y., Ye, Z., Duan, H., Zhao, J., Zhang, H., Narbad, A., Tian, F., Zhai, Q., & Chen, W. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2217727 · Cited by 41
Avenues within the gut-liver-brain axis linking chronic liver disease and symptoms
Nguyen, H. H., & Swain, M. G. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1171253 · Cited by 40
Lan, Z., Tang, X., Lu, M., Hu, Z., & Tang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26377 · Cited by 40
Exploring the gut microbiota and its potential as a biomarker in gliomas
Aljarrah, D., Chalour, N., Zorgani, A., Nissan, T. A., & Pranjol, M. Z. I. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116420 · Cited by 40
Role of the gut microbiota in complications after ischemic stroke
Zhang, J., Ling, L., Xiang, L., Li, W., Bao, P., & Yue, W. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1334581 · Cited by 40
Ghassab, F. T., Mahmoudi, F. S., Tinjani, R. T., Meibodi, A. E., Zali, M. R., & Yadegar, A. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122748 · Cited by 40
A role for microglia in mediating the microbiota–gut–brain axis
Keane, L., Clarke, G. A., & Cryan, J. F. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01188-9 · Cited by 43
Microbiome response to diet: focus on obesity and related diseases
Delzenne, N. M., Rodriguez, J., Olivares, M., & Neyrinck, A. M. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09572-7 · Cited by 40
The Gut Microbiome and Substance Use Disorder
Russell, J. T., Zhou, Y., Weinstock, G. M., & Bubier, J. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.725500 · Cited by 40
Łoniewska, B., Fraszczyk-Tousty, M., Tousty, P., Skonieczna‐Żydecka, K., Maciejewska, D., & Łoniewski, I. (2023) · Nutrients · doi:10.3390/nu15020367 · Cited by 41
Kumari, S., Taliyan, R., & Dubey, S. K. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00730 · Cited by 40
Zhang, S., Jin, M., Ren, J., Sun, X., Zhang, Z., Luo, Y., & Sun, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114559 · Cited by 40
Pessoa, J., Belew, G. D., Barroso, C., Egas, C., & Jones, J. G. (2023) · Nutrients · doi:10.3390/nu15092097 · Cited by 40
Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases
Ryman, S. G., Vakhtin, A. A., Richardson, S. P., & Lin, H. C. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11461-9 · Cited by 39
Homer, B., Judd, J., Dehcheshmeh, M. M., Ebrahimie, E., & Trott, D. J. (2023) · Animals · doi:10.3390/ani13091458 · Cited by 39
Chaľová, P., Ťažký, A., Škultéty, Ľ., Minichová, L., Chovanec, M., Čierniková, S., Mikuš, P., & Piešťanský, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1110235 · Cited by 39
Tian, X.-Y., Dong, W., Zhou, W., Yan, Y., Lu, L., Mi, J., Cao, Y., Sun, Y., & Zeng, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.129036 · Cited by 39
Petakh, P., Oksenych, V., Kamyshna, I. I., Boisak, I., Lyubomirskaya, K., & Kamyshnyi, O. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349883 · Cited by 39
Bashir, B., Alam, S., Khandale, N. B., Birla, D., Vishwas, S., Pandey, N. K., Gupta, G., Paudel, K. R., Dureja, H., Kumar, P., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102236 · Cited by 40
Yamashiro, K., Takabayashi, K., Kamagata, K., Nishimoto, Y., Togashi, Y., Yamauchi, Y., Ogaki, K., Li, Y., Hatano, T., Motoi, Y., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106464 · Cited by 39
Lin, X., Peng, Y., Guo, Z., He, W., Guo, W., Feng, J., Lin, L., Liu, Q., & Xu, P. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05332-x · Cited by 39
Microbiota–gut–brain axis: Natural antidepressants molecular mechanism
Lu, Y., Yu, X., Wang, Z., Kong, L., Jiang, Z., Shang, R., Zhong, X., Lv, S., Zhang, G., Gao, H., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156012 · Cited by 40
Ravikrishnan, A., Wijaya, I., Png, E., Chng, K. R., Ho, E. X. P., Ng, A. H. Q., Naim, A. N. M., Gounot, J.-S., Guan, S. P., Lee, J. H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52097-9 · Cited by 39
Stress triggers gut dysbiosis via CRH-CRHR1-mitochondria pathway
Zhang, Y., Li, X., Lu, S., Guo, H., Zhang, Z., Zheng, H., Zhang, C., Zhang, J., Wang, K., Pei, F., et al. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00571-z · Cited by 39
Li, Y., He, C., & Lü, N. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003348 · Cited by 39
Zhou, X., Li, Y., Yang, Y., Li, W., Wang, C., Xu, J., Song, J., Liu, S., Bai, J., & Suo, H. (2025) · npj Science of Food · doi:10.1038/s41538-025-00416-9 · Cited by 39
Mapping pesticide-induced metabolic alterations in human gut bacteria
Chen, L., Yan, H., Di, S., Guo, C., Zhang, H., Zhang, S., Gold, A., Wang, Y., Hu, M., Wu, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59747-6 · Cited by 39
The Microbiota‐Gut‐Brain Connection: A New Horizon in Neurological and Neuropsychiatric Disorders
Faysal, M. F., Zehravi, M., Sutradhar, B., Amin, M. A., Shanmugarajan, T. S., Arjun, U. V. N. V., Ethiraj, S., Durairaj, A., Dayalan, G., Ahamad, S. K., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70593 · Cited by 41
The gut–brain–circadian axis in anxiety and depression: a critical review
Bautista, J., Hidalgo‐Tinoco, C., Delgado, M. D. C., Viteri-Recalde, J., Guerra-Guerrero, A., & López‐Cortés, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1697200 · Cited by 39
Comparison of serum microbiome composition in bipolar and major depressive disorders
Rhee, S. J., Kim, H.-Y., Lee, Y., Lee, H. J., Park, C. H. K., Yang, J., Kim, Y.-K., Kym, S., & Ahn, Y. M. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.01.004 · Cited by 39
Potential benefits of dietary seaweeds as protection against COVID-19
Tamama, K. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa126 · Cited by 40
Kortesniemi, M. K., Slupsky, C. M., Aatsinki, A., Sinkkonen, J., Karlsson, L., Linderborg, K. M., Yang, B., Karlsson, H., & Kailanto, H.-M. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.129628 · Cited by 39
Zhou, M., Li, D., Xie, K., Xu, L., Kong, B., Wang, X., Tang, Y., Liu, Y., & Huang, H. (2021) · Food & Function · doi:10.1039/d1fo02040d · Cited by 39
Mintál, K., Tóth, A., Hormay, E., Kovács, A., László, K., Bufa, A., Marosvölgyi, T., Kocsis, B., Varga, A., Vizvári, Z., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09350-2 · Cited by 39
Gao, H., Song, R., Li, Y., Zhang, W., Wan, Z., Wang, Y., Zhang, H., & Han, S. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c05677 · Cited by 38
Effects of Tempeh Probiotics on Elderly With Cognitive Impairment
Handajani, Y. S., Turana, Y., Yogiara, Y., Sugiyono, S. P., Lamadong, V., Widjaja, N. T., Christianto, G. A. M., & Suwanto, A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.891773 · Cited by 38
The interaction between intestinal microenvironment and stroke
Zhao, L., Xiao, J., Li, S., Guo, Y., Fu, R., Hua, S., Du, Y., & Xu, S. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14275 · Cited by 38
Ni, Y., Tong, Q., Xu, M., Gu, J., & Ye, H. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04370-7 · Cited by 38
Arabinoxylan Alleviates Obesity by Regulating Gut Microbiota and Bile Acid Metabolism
Lin, J., Liu, H., Sun, Y., Zou, J., Nie, Q., & Nie, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c06392 · Cited by 40
Multi-omics approach identifies gut microbiota variations associated with depression
Hernández-Cacho, A., García-Gavilán, J. F., Atzeni, A., Konstanti, P., Belzer, C., Vioqué, J., Corella, D., Fitó, M., Vidal, J., Mela, V., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00707-9 · Cited by 38
Yue, B., Yu, Z., Lv, C., Geng, X., Wang, Z., & Dou, W. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i30.4378 · Cited by 38
Crosstalks Between Gut Microbiota and Vibrio Cholerae
Qin, Z., Yang, X., Chen, G., Park, C., & Liu, Z. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.582554 · Cited by 38
The neuromicrobiology of Parkinson’s disease: A unifying theory
Muñoz, M., Empadinhas, N., & Cardoso, S. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101396 · Cited by 38
Wang, N., Li, R., Feng, B., Cheng, Y., Guo, Y., & Qian, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042031 · Cited by 38
The Role of MicroRNA and Microbiota in Depression and Anxiety
Rosa, J. M., Formolo, D. A., Yu, J., Lee, T. H.-Y., & Yau, S. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.828258 · Cited by 38
Kim, M., Kim, D. Y., Shin, J. H., Kang, Y., Lee, J. S., Son, J., Jeong, S., Kim, D., Kim, D.-H., Chun, E., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01038-y · Cited by 38
Li, Q., Meng, L., Chen, L., Shi, X., Tu, L., Zhou, Q. G., Yu, J.-L., Liao, X., Zeng, Y., & Yuan, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1185375 · Cited by 38
Short-chain fatty acid – A critical interfering factor for allergic diseases
Liu, Y., Liu, J., Du, M., Hu, Y., Shi, R., Shi, Y., Zhang, S., Zhao, Y., & Lan, J. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110739 · Cited by 37
Dalile, B., Fuchs, A., Torre, D. L., Vervliet, B., Oudenhove, L. V., & Verbeke, K. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.110939 · Cited by 37
Self-citationWei, X., Liang, J., Liu, J., Dai, Y., Leng, X., Cheng, Y., & Chi, L. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117995 · Cited by 37
Montgomery, T. L., Peipert, D., & Krementsov, D. N. (2024) · Immunological Reviews · doi:10.1111/imr.13343 · Cited by 38
Fibre & fermented foods: differential effects on the microbiota-gut-brain axis
Schneider, E., Balasubramanian, R., Ferri, A., Cotter, P. D., Clarke, G. A., & Cryan, J. F. (2024) · Proceedings of The Nutrition Society · doi:10.1017/s0029665124004907 · Cited by 37
Quantifying the varying harvest of fermentation products from the human gut microbiota
Arnoldini, M., Sharma, R., Moresi, C., Chure, G., Chabbey, J., Slack, E. M. C., & Cremer, J. (2025) · Cell · doi:10.1016/j.cell.2025.07.005 · Cited by 40
Mohr, A. E., Mach, N., Pugh, J. N., Grosicki, G. J., Allen, J. M., Karl, J. P., & Whisner, C. M. (2025) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaf037 · Cited by 37
Ketogenic diet inhibits glioma progression by promoting gut microbiota-derived butyrate production
Chen, M., He, Y., Dong, X., Liu, H.-F., Yan, Z., Lu, X.-L., Miao, Q.-Q., Zhao, Q., Zhang, H., Luo, L., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.09.002 · Cited by 37
Liu, F., Cheng, X., Zhong, S., Liu, C., Jolkkonen, J., Zhang, X., Liang, Y., Liu, Z., & Zhao, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01931 · Cited by 37
Retinitis pigmentosa is associated with shifts in the gut microbiome
Kutsyr, O., Maestre‐Carballa, L., Gómez, M. L., Martínez‐García, M., Cuenca, N., & Lax, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-86052-1 · Cited by 37
Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms
Bonomo, R. R., Krämer, S., & Mansuy‐Aubert, V. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0278 · Cited by 37
Altered Vagal Signaling and Its Pathophysiological Roles in Functional Dyspepsia
Li, H., & Page, A. J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.858612 · Cited by 37
Lazăr, V., Holban, A. M., Curuțiu, C., & Diţu, L.-M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.920413 · Cited by 37
A systematic, complexity-reduction approach to dissect the kombucha tea microbiome
Huang, X., Xin, Y., & Lu, T. (2022) · eLife · doi:10.7554/elife.76401 · Cited by 38
Current understanding of the human microbiome in glioma
Liang, J., Li, T., Zhao, J., Wang, C., & Sun, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.781741 · Cited by 37
Liu, S., Loo, Y. T., Li, Z., & Ng, K. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.135802 · Cited by 37
Wang, C., Wu, R. T., Zhang, S., Gong, L., Fu, K., Yao, C., Peng, C. Y., & Li, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115410 · Cited by 37
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation
Preglej, T., Hamminger, P., Luu, M., Bulat, T., Andersen, L., Göschl, L., Stolz, V., Rica, R., Sandner, L., Waltenberger, D., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133393 · Cited by 36
Recent review on selected xenobiotics and their impacts on gut microbiome and metabolome
Jin, Y., Chi, J., LoMonaco, K., Boon, A., & Gu, H. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117155 · Cited by 36
Huang, S., He, Y., Chen, P., Liu, K., & Shaukat, A. (2023) · Animal Diseases · doi:10.1186/s44149-023-00089-5 · Cited by 36
Vicariotto, F., Malfa, P., Torricelli, M., Lungaro, L., Caio, G., & Leo, V. D. (2023) · Nutrients · doi:10.3390/nu15163513 · Cited by 36
Neuroactive metabolites modulated by the gut microbiota in honey bees
Cabirol, A., Moriano‐Gutierrez, S., & Engel, P. (2023) · Molecular Microbiology · doi:10.1111/mmi.15167 · Cited by 36
Pan, Z., Wu, N., & Jin, C. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/3080969 · Cited by 36
Sah, R. K., Nandan, A., Athira, K. V., Prashant, S. K., Sankaran, S., Jose, A., Venkidasamy, B., & Nile, S. H. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103861 · Cited by 37
Huang, X., Liu, R., Wang, J., Bao, Y., Yi, H., Wang, X., & Lü, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.129152 · Cited by 37
Hu, H., Sun, W., Zhang, L., Zhang, Y., Kuang, T., Qu, D., Lian, S., Hu, S., Cheng, M., Xu, Y., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129590 · Cited by 36
Zhen, M., Xu, Y. M., Wang, C., & Bai, C. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202409319 · Cited by 36
Behler-Janbeck, F., Baranowsky, A., Yorgan, T. A., Jaeckstein, M. Y., Worthmann, A., Fuh, M. M., Gunasekaran, K., Tiegs, G., Amling, M., Schinke, T., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1392418 · Cited by 37
Role of fructooligosaccharides in promoting beneficial gut bacteria: A Prebiotic perspective
Singh, P., Gupta, S., Kundu, A., Grover, M., & Saha, S. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105726 · Cited by 36
Holcomb, M., Marshall, A., Flinn, H., Lozano-Cavazos, M., Soriano, S., Gómez‐Pinilla, F., Treangen, T. J., & Villapol, S. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03419-1 · Cited by 36
Wei, Y., Chang, L., Ishima, T., Wan, X., Ma, L., Wuyun, G., Pu, Y., & Hashimoto, K. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100198 · Cited by 36
Caffaratti, C., Plazy, C., Méry, G., Tidjani, A.-R., Fiorini, F., Thiroux, S., Toussaint, B., Hannani, D., & Gouëllec, A. L. (2021) · Metabolites · doi:10.3390/metabo11060406 · Cited by 36
Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection
Manosso, L. M., Arent, C. O., Borba, L. A., Ceretta, L. B., Quevedo, J., & Réus, G. Z. (2021) · Cells · doi:10.3390/cells10081993 · Cited by 36
The Role of Gut Microbiota in the Skeletal Muscle Development and Fat Deposition in Pigs
Han, Q., Huang, X., Yan, F., Yin, J., & Xiao, Y. (2022) · Antibiotics · doi:10.3390/antibiotics11060793 · Cited by 37
Zhang, S., Wei, D., Lv, S., Wang, L., An, H., Shao, W., Wang, Y., Huang, Y., Peng, D., & Zhang, Z. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220532 · Cited by 36
Tributyrin supplementation in fish and crustacean nutrition: A review
Palma, M., Magnoni, L. J., Morais, S., & Viegas, I. (2022) · Reviews in Aquaculture · doi:10.1111/raq.12759 · Cited by 36
Short-chain fatty acids in patients with schizophrenia and ultra-high risk population
Peng, H., Ouyang, L., Li, D., Li, Z., Liu, Y., Fan, L., Liao, A., Li, J., Wei, Y., Yang, Z., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.977538 · Cited by 36
Metadata
- Authors
- Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Verbeke, Kristin
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-05-23
- Volume
- 16
- Issue
- 8
- Pages
- 461-478
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2946372752
- Cited by
- 3,357
- References
- 289
- Citations by year
- 2026: 631 · 2025: 685 · 2024: 567 · 2023: 511 · 2022: 429 · 2021: 334 · 2020: 174 · 2019: 25
- FWCI
- 21.30
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- short-chain fatty acids, microbiota-gut-brain axis, dietary fiber fermentation, gut microbiota, psychological functioning, emotional processing, cognitive processes, prebiotics, probiotics, microbiota-targeted interventions, immune signaling, hormone signaling, psychobiology
- MeSH terms
- Gastrointestinal Microbiome, Animals, Mental Disorders, Brain, Dietary Fiber, Disease Models, Animal, Fatty Acids, Volatile, Humans, Neural Pathways, Signal Transduction, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
